Patents by Inventor Jinyu Mo

Jinyu Mo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260124307
    Abstract: The disclosure belongs to the technical field of biomedicine, and specifically relates to an application of DHA@ZIF-8 in the treatment of experimental cerebral malaria. In the disclosure, an experimental cerebral malaria model is first established. Subsequently, DHA@ZIF-8 is used for treatment in the model, and the therapeutic efficacy of the nanodrug against experimental cerebral malaria is evaluated using behavioral, pathological, and molecular biological techniques. In the disclosure, the use of ZIF-8 as a carrier achieves the effect of slowly releasing the drug, prolonging the duration of action of the drug in vivo, so as to more effectively kill Plasmodium. Compared with natural administration, this approach extends the duration of action of DHA.
    Type: Application
    Filed: September 24, 2025
    Publication date: May 7, 2026
    Applicants: Hubei University of Medicine, Tongji University
    Inventors: Jian Li, Qingfeng Zhang, Jinyu Mo, Junming Tang
  • Publication number: 20260115233
    Abstract: The disclosure belongs to the technical field of biomedicine, and specifically relates to an application of Akkermansia muciniphila (AKK) in the amelioration and treatment of cerebral malaria caused by Plasmodium berghei. The disclosure aims to evaluate the efficacy of AKK alone or in combination with adjuvant drugs (dihydroartemisinin, rapamycin, and atorvastatin) in ameliorating and treating experimental cerebral malaria in an experimental cerebral malaria model. The results indicate that AKK, whether used alone or in combination with drugs, can effectively ameliorate behavioral deficits and immunopathological damage of each organ, lower parasitemia levels, and prolong survival period of mice. Compared with the use of drug alone, the combination therapy can effectively treat the experimental cerebral malaria. The disclosure is the first to propose the concept of bacterial-drug synergy concept, and provides a solution to the treatment of human cerebral malaria on the basis of the concept.
    Type: Application
    Filed: September 24, 2025
    Publication date: April 30, 2026
    Applicants: Hubei University of Medicine, Tongji University
    Inventors: Jian Li, Qingfeng Zhang, Junming Tang, Daiqian Zhu, Jinyu Mo
  • Publication number: 20090136241
    Abstract: A method of generating an optical minimum shift keying (MSK) modulated signal, a method of pre-coding an input data stream for generation of an optical MSK modulated signal, a method of decoding an optical MSK modulated signal, an MSK transmitter, an encoder structure for encoding an input data stream for generation of an optical MSK modulated signal, and a receiver structure for decoding an optical MSK modulated signal.
    Type: Application
    Filed: February 8, 2006
    Publication date: May 28, 2009
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Jinyu Mo, Yi Dong